Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat3
PYC Share
Trades9
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
PYC Company
Research
PYC Company
Timeline
Share Price Information for Physiomics (PYC)
Last checked at -
Last checked at 
Intraday Physiomics Share Chart
LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.
Latest PYC News
- Physiomics to work with University of Sheffield on cancer research
31 May 2023 - Physiomics shares drop after it cuts full-year guidance
23 May 2023 - AIM WINNERS & LOSERS: Physiomics falls as lowers full-year guidance
23 May 2023 - TRADING UPDATES: Narf Industries audit delay; Arecor wins patent
26 Apr 2023 - Physiomics inks collaboration deal with ValiRx subsidiary
26 Apr 2023 - Physiomics to present work at US cancer research summit
14 Apr 2023 - Physiomics shares drop as laments lack of funding for biotechnology
4 Apr 2023 - AIM WINNERS & LOSERS: Light Science shares plummet on fundraise
4 Apr 2023
Related News
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics reports strong operational progress
(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...
Physiomics hails progress despite one-off costs to replace board
(Alliance News) - Physiomics PLC on Friday said it "continues to make strong operational progress" but noted one-off costs from the dismissal of its p...
Physiomics News
Physiomics to work with University of Sheffield on cancer research
(Alliance News) - Physiomics PLC on Wednesday said it will collaborate with the University of Sheffield on research into an insect model of cancer tre...
Physiomics shares drop after it cuts full-year guidance
(Alliance News) - Physiomics PLC shares fell on Tuesday, after it lowered its full-year outlook by more than 10%.
AIM WINNERS & LOSERS: Physiomics falls as lowers full-year guidance
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
TRADING UPDATES: Narf Industries audit delay; Arecor wins patent
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Physiomics inks collaboration deal with ValiRx subsidiary
(Sharecast News) - Physiomics announced on Wednesday that it has signed a collaborative services agreement with Inaphaea BioLabs - a wholly-owned subs...
Physiomics to present work at US cancer research summit
(Sharecast News) - Physiomics announced its participation in the American Association for Cancer Research (AACR) annual meeting on Friday, being held ...
Physiomics shares drop as laments lack of funding for biotechnology
(Alliance News) - Physiomics PLC on Tuesday announced that its revenue was hampered by pressure resulting from low biotechnology funding.
AIM WINNERS & LOSERS: Light Science shares plummet on fundraise
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Follow the stocks
